JP2005523681A5 - - Google Patents

Download PDF

Info

Publication number
JP2005523681A5
JP2005523681A5 JP2003532654A JP2003532654A JP2005523681A5 JP 2005523681 A5 JP2005523681 A5 JP 2005523681A5 JP 2003532654 A JP2003532654 A JP 2003532654A JP 2003532654 A JP2003532654 A JP 2003532654A JP 2005523681 A5 JP2005523681 A5 JP 2005523681A5
Authority
JP
Japan
Prior art keywords
ulbp4
protein
seq
polypeptide
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003532654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005523681A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/031994 external-priority patent/WO2003029436A2/en
Publication of JP2005523681A publication Critical patent/JP2005523681A/ja
Publication of JP2005523681A5 publication Critical patent/JP2005523681A5/ja
Pending legal-status Critical Current

Links

JP2003532654A 2001-10-04 2002-10-04 Ul16結合タンパク質4 Pending JP2005523681A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32725201P 2001-10-04 2001-10-04
PCT/US2002/031994 WO2003029436A2 (en) 2001-10-04 2002-10-04 Ul16 binding protein 4

Publications (2)

Publication Number Publication Date
JP2005523681A JP2005523681A (ja) 2005-08-11
JP2005523681A5 true JP2005523681A5 (https=) 2006-01-05

Family

ID=23275763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003532654A Pending JP2005523681A (ja) 2001-10-04 2002-10-04 Ul16結合タンパク質4

Country Status (10)

Country Link
US (2) US7563450B2 (https=)
EP (1) EP1451333B1 (https=)
JP (1) JP2005523681A (https=)
AT (1) ATE434624T1 (https=)
AU (1) AU2002340118B2 (https=)
CA (1) CA2462790A1 (https=)
DE (1) DE60232742D1 (https=)
MX (1) MXPA04003057A (https=)
PL (1) PL373594A1 (https=)
WO (1) WO2003029436A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003225093A1 (en) * 2002-04-22 2003-11-03 Fred Hutchinson Cancer Research Center Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions
US20060247420A1 (en) * 2002-09-04 2006-11-02 George Coukos Immune cell recptor ligand and immune cell receptor
US7666417B2 (en) * 2003-04-22 2010-02-23 Fred Hutchinson Cancer Research Center Methods and compositions for treating autoimmune diseases or conditions
EA014640B1 (ru) * 2003-07-21 2010-12-30 Иммьюноджен, Инк. Антитело или его эпитоп-связывающий фрагмент, которые связываются с гликотопом са6, и способы их применения
US7834155B2 (en) 2003-07-21 2010-11-16 Immunogen Inc. CA6 antigen-specific cytotoxic conjugate and methods of using the same
US7998481B2 (en) 2004-04-05 2011-08-16 The Regents Of The University Of California Modulation of NKG2D for treating or preventing solid organ allograft rejection
DE102004042894A1 (de) * 2004-08-30 2006-03-02 Eberhard-Karls-Universität Tübingen Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen
JP2008521814A (ja) * 2004-11-24 2008-06-26 シェーリング コーポレイション Dap−10およびその使用
US9593347B2 (en) 2010-04-16 2017-03-14 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
US20130156808A1 (en) * 2011-11-22 2013-06-20 Stipan Jonjic Vaccine comprising beta-herpesvirus
JP6518199B6 (ja) 2013-03-15 2019-06-12 ノヴェロジックス・バイオテクノロジー,インコーポレーテッド Micaおよびmicbタンパク質に対する抗体
CN106068326B (zh) 2013-10-28 2021-06-18 联邦高等教育系统-匹兹堡大学 溶瘤性hsv载体
RU2749050C2 (ru) 2016-01-27 2021-06-03 Онкорус, Инк. Онколитические вирусные векторы и их применение
CN109475613B (zh) 2016-06-14 2024-02-20 匹兹堡大学-属高等教育联邦体系 使癌细胞对胞毒免疫细胞攻击敏感的nkg2d活化配体蛋白表达
RU2021127872A (ru) 2016-06-30 2021-11-09 Онкорус, Инк. Доставка терапевтических полипептидов посредством псевдотипированных онколитических вирусов
CA3040421A1 (en) 2016-10-19 2018-04-26 Novelogics Biotechnology, Inc. Antibodies to mica and micb proteins
AU2018306455A1 (en) 2017-07-26 2020-02-27 Virogin Biotech Canada Ltd Oncolytic viral vectors and uses thereof
WO2019028336A1 (en) * 2017-08-03 2019-02-07 The Cleveland Clinic Foundation IMPROVED PEPTIDE EXPRESSION AND ANTIBODY DETECTION OF APO-H SPECIFIC SUBJECT
US11865081B2 (en) 2017-12-29 2024-01-09 Virogin Biotech Canada Ltd. Oncolytic viral delivery of therapeutic polypeptides
CN112285360B (zh) * 2020-09-23 2023-08-22 台州市第一人民医院 I-309在制备原发性干燥综合征诊断试剂或试剂盒中的应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US22239A (en) * 1858-12-07 Limekiln
US4311A (en) * 1845-12-16 William beebe
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
DE4118120A1 (de) 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US20030004311A1 (en) 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030022239A1 (en) 1997-06-18 2003-01-30 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU742757C (en) * 1997-12-17 2007-05-17 Immunex Corporation Cell surface glycoproteins associated with human B cell lymphomas - ULBP, DNA and polypeptides
DE69841110D1 (de) * 1997-12-17 2009-10-08 Serono Genetics Inst Sa Verlängerte cdns, die für sekretierte proteine kodieren
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
JP2003505082A (ja) 1999-07-26 2003-02-12 ジェネンテック・インコーポレーテッド 新規なポリヌクレオチドとその使用法
EP1672070A3 (en) 1999-12-01 2006-10-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20040034192A1 (en) 2000-01-06 2004-02-19 Seishi Kato Human proteins having hyprophobic domains and dnas encoding these proteins
US20040219521A1 (en) * 2000-01-21 2004-11-04 Tang Y. Tom Novel nucleic acids and polypeptides
CN1423700A (zh) 2000-03-24 2003-06-11 麦克美特股份公司 含有针对nkg2d受体复合物的表位的结合位点的多功能多肽
US20050074754A1 (en) * 2000-04-27 2005-04-07 Shoichi Okubo Novel protein and use thereof
AU5943201A (en) 2000-05-03 2001-11-12 Amgen Inc Modified peptides as therapeutic agents
WO2002068615A2 (en) 2001-02-28 2002-09-06 Fred Hutchinson Cancer Research Center, Inc. Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
US6821522B2 (en) * 2001-05-31 2004-11-23 The Regents Of The University Of California Tumor Therapy
US20060127894A1 (en) 2001-08-08 2006-06-15 Incyte Corporation Protein associated with cell growth, differentiation, and death
EP1504099A4 (en) 2001-12-10 2006-05-10 Nuvelo Inc NEW NUCLEIC ACIDS AND POLYPEPTIDES
WO2003074556A1 (fr) 2002-03-04 2003-09-12 Shanghai Genomics, Inc. Marqueur tumoral et ses applications
US20060247420A1 (en) 2002-09-04 2006-11-02 George Coukos Immune cell recptor ligand and immune cell receptor

Similar Documents

Publication Publication Date Title
JP2005523681A5 (https=)
Sillanpää et al. Characterization of the collagen-binding S-layer protein CbsA of Lactobacillus crispatus
JP2006515749A5 (https=)
JP7164598B2 (ja) トランスジェニックマクロファージ、キメラ抗原受容体、及び関連する方法
JP2019519215A5 (https=)
JP2009506762A5 (https=)
CN120924491A (zh) 多链嵌合多肽和其用途
JP2003502283A5 (https=)
JP2010529860A5 (https=)
JPH06501456A (ja) 表面複合リンホトキシン
JP2016508143A5 (https=)
TW416960B (en) Reshaped human antibody to human interleukin-8
JP2010538619A5 (https=)
JP2005507648A5 (https=)
CN104292337A (zh) 猪融合干扰素
JP2004532037A5 (https=)
JP4592756B2 (ja) 高分子形マンノース結合型レクチンの大量生産方法
JP2003527073A5 (https=)
KR100801810B1 (ko) 슈퍼-항원 융합 단백질들 및 그 용도
WO2003097814A3 (en) Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
WO2001064913A3 (en) Cell cycle proteins associated with rad9, compositions and methods of use
JP2006525786A5 (https=)
CN106496329B (zh) 一种含有胶原蛋白结合结构域的融合蛋白
CN103789340A (zh) 一种高效制备重组人mica蛋白的方法
JP2008509659A5 (https=)